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ABSTRACT:	  The	  current	  surge	  of	  interest	  to	  define	  glycobiomarkers	  by	  applying	  lectins	  rekindles	  the	  interest	  to	  define	  the	  docking	  sites	  of	   lectins	  at	   the	  highest	  possible	  resolution.	  Of	  note,	  natural	  complex-­‐type	  N-­‐glycans	  can	  present	  more	  than	  one	  potential	  binding	  site,	  posing	  the	  question	  on	  the	  actual	  interaction	  when	  interpreting	  e.	  g.	  lectin	  array	  data.	  By	  strategi-­‐cally	  combining	  chemoenzymatic	  N-­‐glycan	  synthesis	  with	  STD	  NMR	  spectroscopy	  and	  modeling	  we	  illustrate	  that	  epitope	  recognition	  can	  depend	  on	  the	  structural	  context	  (for	  the	  sugar	  and	  the	  lectin,	  here	  wheat	  germ	  agglutinin	  and	  a	  single	  hev-­‐ein	  domain).	  Equally	   important,	  we	  monitor	  branch-­‐end	  substitutions	  by	  this	  strategy	  and	  describe	  a	  3D	  structure	  which	  accounts	  for	  the	  accommodation	  of	  the	  α2,6-­‐sialylated	  terminus	  of	  a	  complex	  N-­‐glycan	  by	  a	  plant	  lectin.	  The	  given	  approach	  is	  thus	  instrumental	  to	  pinpoint	  sites	  for	  lectin	  molecular	  recognition	  by	  glycans	  of	  natural	  complexity.	  
Introduction	  Molecular	  recognition	  is	  at	  the	  heart	  of	  essential	  biologi-­‐cal	   events.	   The	   recognition	   of	   saccharides	   presented	   as	  part	  of	  natural	  scaffolds	  (protein,	  sphingolipids)	  by	  protein	  receptors	   (lectins)	   mediates	   key	   processes	   underlying	  many	  aspects	  of	  life	  as	  reflected	  by	  the	  term	  ‘sugar	  code’.1	  Matching	  the	  wide	  spectrum	  of	  glycan	  structures	  (glycome	  complexity2),	   lectins	   are	   found	   in	   all	   branches	   of	   the	  phylogenetic	   tree	  and	  proved	  to	  be	  versatile	  tools	   for	  gly-­‐can	   detection	   and	   structural	   characterization.3	   There	   is	  particular	  interest	  in	  the	  identification	  of	  glycoprotein	  gly-­‐can	   structures	   as	   a	   result	   of	   altered	   glycoprotein	   expres-­‐sion	  occurring	   in	  diseases,	  hereby	  defining	   functional	  gly-­‐cobiomarkers	   of	   diagnostic	   value.4	   Recent	   technological	  advances	  have	  lead	  to	  the	  employment	  of	  lectin	  and	  glycan	  microarrrays,	  which	  offer	  a	  macroscopic	  view	  of	  the	  lectin-­‐glycan	   interactions,	   and	   provide	   a	   high-­‐throughput	   ap-­‐proach	  to	  screen	  a	  wide	  range	  of	  glycan	  profiles	  and	  glycan	  binding	  specificity	  of	  the	  lectin.5	  	  With	   the	  growing	  realization	   that	   the	  way	  a	  glycan	  epi-­‐tope	  is	  presented	  affects	   its	  reactivity	  for	   lectins3b	   it	   is	  es-­‐sential	   to	   study	   this	   interaction	   with	   glycans	   equalling	  their	  natural	  size	  and	  rigorously	  define	  the	  contact	  sites.	  	  NMR	  and	  X-­‐ray	  crystallography	  provide	  key	  information	  at	   atomic	   resolution	   on	   the	   studied	   molecules,	   including	  
complexes.	   In	   the	   protein-­‐carbohydrate	   interaction	   field,	  these	   techniques	   have	  mainly	   focused	   on	   acquiring	   infor-­‐mation	   on	   those	   complexes	   formed	   by	   lectins	   and	  small/medium	   size	   oligosaccharide	   fragments.	   Probably,	  the	  chemical	  complexity	  and	  flexibility	  of	  the	  whole	  glycan	  structures	   occurring	   in	   Nature	   have	   often	   impaired	   the	  detailed	   analysis	   of	   the	   corresponding	   complexes.	   Due	   to	  remarkable	   progress	   in	   chemical	   synthesis	   of	   N-­‐glycans,	  which	  have	   facilitated	   to	  relate	  structural	  aspects	  of	   com-­‐plex-­‐type	  N-­‐glycans	  such	  as	  core	  substituions	   to	   lectin	  af-­‐finity,6	  and	  the	  powerful	  NMR-­‐based	  techniques	  to	  monitor	  the	  recognition	  process7	  these	  studies	  are	  possible.	  	  Herein,	  we	  demonstrate	  that	  NMR	  spectroscopy,	  applied	  from	  the	  perspective	  of	   the	   ligand,	   can	  be	  efficiently	  used	  to	   obtain	   high-­‐resolution	   information	   on	   these	  molecular	  recognition	  processes.	  As	  model	  system,	  the	  interaction	  of	  complex-­‐type	   biantennary	  N-­‐glycans	  with	   four	   plant	   lect-­‐ins	  of	  different	  specificities,	  topologies	  and	  folding	  features	  was	  investigated.	  On	   the	   side	   of	   the	   glycans,	  we	   include	   the	   biantennary	  complex-­‐type	   nonasaccharide	   (with	   N-­‐acetyllactosamine	  (LacNAc)	   termini)	   and	   its	   α2,6-­‐sialylated	   undecasaccha-­‐ride,	   which	   were	   isolated	   from	   egg	   yolk,	   as	   well	   as	   the	  
α2,6-­‐sialyl-­‐LacNAc	   trisaccharide	   (Figure	   1).	   These	   struc-­‐tures	  represent	  common	  motifs	  of	  N-­‐glycans	  on	  glycopro-­‐
 teins,	   α2,6-­‐sialylation	   acting	   as	   salient	   signal	   for	   mask-­‐ing/docking.8	   From	   the	   lectin	   side,	   two	   agglutinins	   with	  reactivity	  to	  the	  N,N’-­‐diacetylchitobiose	  ((GlcNAc)2)	  of	   the	  core	  were	  chosen,	  i.	  e.	  wheat	  germ	  agglutinin	  (WGA)9	  and	  a	  WGA-­‐derived	   single	   domain	   similar	   to	   hevein.10	   Hevein,	  one	  of	  the	  smallest	  plant	   lectins	  with	  43	  amino	  acids,	  was	  the	   first	   lectin	  whose	   structure	   in	   complex	  with	   its	   sugar	  ligand	  has	  been	  solved	  in	  solution.11	  Its	  reactivity	  is	  repre-­‐sented	  by	  the	  so-­‐called	  hevein	  domain,	  present	  in	  WGA.	  Of	  note,	  WGA	   is	   also	   reactive	  with	  N-­‐acetylneuraminic	   acid.9	  Seeds	  of	  Maackia	  amurensis	  are	  the	  source	  of	  two	  aggluti-­‐nins	   (the	   leukoagglutinin	   MAL	   and	   the	   haemagglutinin	  MAA),	   which	   differ	   in	   their	   requirement	   for	   α2,3-­‐sialylation	  of	  a	  LacNAc	  terminus.9,	  12	  In	  contrast,	  the	  Viscum	  
album	   agglutinin	   (viscumin,	   VAA)	   is	   known	   to	   react	  with	  LacNAc-­‐terminated	  and	  α2,6-­‐sialylated	  N-­‐glycans.13	  We	  show	  that	  the	  mode	  of	  glycan	  presentation	  is	  crucial	  for	  recognition,	  and	  that	  the	  selectivity	  observed	  in	  assays	  with	   free	   sugars	   might	   change	   with	   subtle	   alterations	   in	  the	   N-­‐glycan	   structure.	   Additionally,	   the	   importance	   of	  multivalency	  could	  also	  be	  deduced	  from	  our	  experiments.	  	  	  
Methods.	  NMR.-­‐	  The	  1H-­‐NMR	  resonances	  of	  the	  ligands	  were	  com-­‐pletely	   assigned	   through	   standard	   TOCSY	   (60	   ms	   mixing	  time),	   NOESY	   (300	   and	   500	   ms	   mixing	   time)	   and	   HSQC	  experiments	   at	   800	   MHz	   (cryo)	   and	   600	   MHz	   spectrom-­‐eters.	  Typical	  concentrations	  were	  1	  mM	  for	  the	  homonu-­‐clear	  and	  2	  mM	  for	  the	  heteronuclear	  experiments.	  	  The	  samples	  for	  STD	  experiments	  as	  adapted	  to	  lectins14	  were	  prepared	   in	  PBS	  buffer	   (MAA	  and	  WGA	  pH=5.7,	  and	  pH=7.3	   for	   viscumin)	   using	   ligand/lectin	   ratios	   varying	  from	   1:20	   to	   1:100.	   The	   applied	   temperatures	   varied	   be-­‐tween	  283	  K	  and	  303	  K.	  Molar	  ratio	  and	  temperature	  were	  optimized	   in	   each	   case.	   Representative	   experiments	   with	  significant	  STD	  responses	  are	  presented	  in	  the	  figures.	  Data	   from	   1D	   STD	   experiments	   were	   acquired	   at	   600	  and	  500MHz	  using	  a	  Gaussian	  pulse	  (49	  ms)	  cascade	  sepa-­‐rated	   by	   1	   ms	   delays.	   STD-­‐TOCSY	   experiments	   were	   ac-­‐quired	   at	   500MHz,	   using	   256	   increments	   and	   a	   isotropic	  mixing	   time	   of	   60	  ms.	   In	   all	   cases,	   the	   on-­‐resonance	   fre-­‐quency	   was	   set	   at	   the	   aromatic	   or	   aliphatic	   regions	   (6.9	  ppm	  or	  0.5	  ppm,	  respectively),	  and	  a	  series	  of	  experiments	  were	   recorded,	  where	   the	   saturation	   time	  was	   varied	  be-­‐tween	   200	   ms	   and	   2s.	   The	   off-­‐resonance	   frequency	   was	  always	   set	   at	   100	   ppm.	   Under	   these	   conditions,	   the	   free	  ligand	   in	   solution	   showed	   residual	   STD	   intensities	   in	   the	  1D	  STD	  spectra	  that	  were	  taking	  into	  account	  when	  analys-­‐ing	  the	  STD	  spectra.	  Molecular	   modelling.-­‐	   The	   starting	   structures	   for	   the	  docking	  procedures	  were	  built	  by	  taking	  as	  starting	  points	  X-­‐ray	  structures	  of	   the	   lectin	  complexed	  with	  small	  oligo-­‐saccharides	   pdb	   codes:	   2UVO	   and	   2CWG	   for	  WGA,	   1DBN	  for	  maackia	  amurensis	  and	  1PUU	   for	  viscumin.	  The	  struc-­‐ture	   of	   the	  N-­‐glycan	  was	  manually	   docked	   in	   the	   binding	  site	  working	  with	  the	  most	  populated	  conformation	  found	  for	  the	  free	  state	  (according	  to	  a	  standard	  NOE/molecular	  modelling	   approach).	   The	   complex	   structure	   was	   then	  submitted	  to	  a	  short	  MD	  run,	  followed	  by	  energy	  minimiza-­‐tion	  with	   a	   low	   gradient	   convergence	   threshold	   (0.02)	   in	  
5000	  steps.	  In	  all	  cases,	  the	  OPL2005	  force	  field15	  was	  em-­‐ployed,	   as	   integrated	   in	   the	  Schroedinger	  MAESTRO	  suite	  of	  programms.16	  Lectins.-­‐	   WGA	   and	   MAA	   were	   purchased	   from	   Sigma-­‐Aldrich,	   VAA	   was	   obtained	   and	   controlled	   for	   purity	   as	  described,17	  and	  WGA-­‐B	  domain	  was	  also	  obtained	  as	  pre-­‐viously	  described.18	  Ligands.-­‐	   Compound	   5	   was	   purched	   from	   Sigma	   Ald-­‐ridch.	  Compounds	  1,19	  2	  and	  4	  were	  obtained	  as	  previously	  described.20	   Compound	   3	   was	   prepared	   from	   its	   corre-­‐sponding	   sialylated	   undecasaccharide-­‐glycopeptide,	   that	  was	   obtained	   from	   egg	   yolk	   in	   analogy	   to	   the	   published	  procedures.21	   This	   undecasaccharide-­‐glycopeptide	   5.7	  mg	  (2	  µmol)	  was	  dissolved	  in	  400	  µL	  of	  phosphate	  buffer	  (75	  mM;	  pH	  6)	  and	  a	  solution	  of	  0.2	  mg	  (0.6	  U)	  of	  neuramini-­‐dase	   from	   Clostridium	   perfringens	   (Sigma	   Aldrich,	   EC:	  3.2.1.18)	  in	  50	  µL	  of	  phosphate	  buffer	  (75	  mm,	  pH	  6)	  was	  added.	  The	  mixture	  was	  incubated	  at	  ambient	  temperature	  for	   3d	   (TLC:	   2-­‐propanol/	   1	   M	   ammonium	   acetate	   1.5:1),	  cleared	  by	  centrifugation	  and	  the	  supernatant	  was	  purified	  by	   gel	   filtration	   (Superdex	   30	   (1.6	   x	   60cm);	   flow	   rate	  1mL/min;	  eluent	  0.1	  m	  NH4HCO3;	  detection	  214	  nm).	  The	  fractions	  eluting	  at	  77	  min	  were	  collected,	  lyophilized	  and	  desalted	  by	  gel	  filtration	  (Sephadex	  G25	  (2.5	  x	  70	  cm);	  flow	  rate	  1	  mL/min;	  eluent	  5%	  ethanol	  in	  water;	  detection	  214	  nm).	  The	  fractions	  eluting	  at	  201	  min	  were	  lyophilized	  and	  yielded	   4.05	   mg	   of	   nonasaccharide-­‐glycopeptide	   3	   (98.2	  %)	  
	  
Results.	  
Monovalent	  verus	  multivalent	   lectins:	  hevein	  domain	  and	  
WGA.	  	  The	   recognition	   features	   of	   chitooligosaccharides	   by	  hevein	   domains	   have	   been	   well	   established	   through	  NMR.10,	   11	   More	   recently,	   we	   have	   demonstrated	   that	   the	  trisaccharide	  N-­‐glycan	  core	   (1)	   is	  also	  recognised	  by	  hev-­‐ein,	  with	  GlcNAc1	  (linked	  to	  Asn)	  on	  subsite	  +2	  (on	  top	  of	  W21),	  GlcNAc2	  on	  subsite	  +1	  (on	  top	  of	  W23)	  and	  βMan	  at	  subsite	  -­‐1,	  leaving	  the	  Asn	  residue	  outside	  the	  binding	  site,	  without	   establishing	   interactions	   with	   the	   lectin.19	   This	  structural	  model	  was	   used	   as	   template	   for	   analyzing	   rec-­‐ognition	   of	   complex-­‐type	   N-­‐glycans.	   However,	   when	   we	  titrated	  a	  0.3mM	  solution	  of	  a	  single	  hevein	  domain	  (the	  B-­‐domain	  of	  WGA18	  with	  increasing	  amounts	  of	  the	  sialylated	  
N-­‐glycan	   4	   (figure	   SuppInfo),	   no	   changes	   at	   all	   were	   ob-­‐served	  on	   the	   1H	  NMR	   resonances	  of	   the	   lectin.	   Similarly,	  attempts	  to	  dock	  the	  undecasaccharide	  4	  using	  the	  binding	  mode	  of	   the	  core	   trisaccharide-­‐Asn	  glycopeptide	   (1)	   (Fig-­‐ure	  2)	  were	  unsuccessful.	  In	  fact,	  branching	  at	  position	  6	  of	  the	  central	  βMan	  residue	  causes	  a	  steric	  clash	  of	  the	  sugar	  extension	  with	   different	   protein	   residues,	   independent	   of	  the	  presence	  of	  either	  gg	  or	  gt	  rotamers	  at	  the	  C5-­‐C6	  link-­‐age.	  By	  contrast,	  WGA	  is	  known	  to	  react	  with	  N-­‐glycans.9	  WGA	   is	   a	  dimeric	   lectin	  where	   each	   subunit	   consists	  of	  an	   assembly	   of	   4	   hevein	   domains.22	   Therefore,	   WGA	   is	  composed	  of	  8	  hevein	  domains.	  It	  has	  been	  described	  to	  be	  specific	  for	  terminal	  Neu5Ac	  and	  GlcNAc	  moieties,	  by	  inhi-­‐bition	  studies,9	  crystallography22	  and	  NMR	  spectroscopy.23	  The	   structure	   of	   complexes,	   also	   with	   a	   sialoglycopep-­‐tide,22c	  reveals	  that	  the	  primary	  binding	  site	  is	  constituted	  
 by	   three	   conserved	   aromatic	   residues	   from	   one	   hevein	  domain,	  but	   further	  polar	  residues	  (S114	  and	  E115)	   from	  the	  neighbouring	  hevein	  domain	  contribute	   to	   the	  stabili-­‐zation	  of	   the	  complex,	  providing	  structural	  evidence	   for	  a	  intra-­‐protein	  cooperation	  of	  lectin	  domains.	  	  Strikingly,	   in	  contrast	  with	  the	  observations	  for	  the	  sin-­‐gle	  hevein	  domain,	  the	  STD	  experiments	  performed	  for	  the	  sialylated	  N-­‐glycan	  4	   in	   the	   presence	   of	   the	  multidomain	  lectin	  showed	  STD	  signals,	  evidencing	  an	  interation.	  Analy-­‐sis	   of	   the	   STD	   spectra	   (Figures	   3	   and	   4)	   clearly	   showed	  that	   recognition	   does	   not	   involve	   the	   terminal	   Neu5Ac	  residue.	  Only	  a	  weak	  effect	  is	  observed	  in	  the	  methyl	  group	  of	  the	  acetamide,	  while	  the	  ring	  hydrogens	  do	  not	  show	  up	  in	  the	  STD	  spectrum.	  In	  fact,	  the	  residues	  in	  closer	  contact	  with	   the	   protein	   are	   at	   the	   opposite	   end	   of	   the	  molecule,	  namely	  GlcNAc1	  and	  Asn.	  Thus,	  the	  binding	  mode	  is	  differ-­‐ent	  to	  that	  occurring	  between	  a	  single	  hevein	  domain	  (Fig-­‐ure	   2A)	   and	   the	   trisaccharide	   core	   (1),	   in	   which	   the	   Asn	  moiety	  was	  far	  from	  the	  lectin	  (positive	  NOEs	  in	  the	  NOESY	  spectrum	  of	  the	  complex).19	  For	  hevein	  itself,	  GlcNAc1	  and	  GlcNAc2	   are	   located	   at	   subsites	   +2	   and	   +1	   respectively.	  However,	   for	   WGA,	   the	   docking	   procedure	   based	   on	   the	  experimental	  observations	  showed	  that	   the	  binding	  mode	  is	   shifted	   by	   one	   subsite:	   the	   Asn	   residues	   now	   occupies	  subsite	  +2	   (on	   top	  of	  W21),	  GlcNAc1	   is	  on	   subsite	  +1	   (on	  top	  of	  W23)	  and	  GlcNAc2	   sits	  on	   subsite	   -­‐1.	   In	   this	   situa-­‐tion,	  the	  βMan	  residue	  is	  shifted	  one	  subsite	  away	  from	  the	  center	   of	   binding	   to	   the	  protein	   and	   therefore	   the	   tpyical	  branching	  at	  O6	  now	  does	  not	  cause	  steric	  clashes	  with	  the	  protein	   (Figure	   5).	   Obviously,	   one	   question	   arises:	  why	   a	  single	   hevein	   domain	   does	   not	   use	   this	   binding	  mode	   for	  recognizing	   the	   large	   N-­‐glycan	   4.	   Detailed	   comparison	  points	   to	   the	   presence	   of	   the	   additional	   polar	   residues	   in	  the	   neighbouring	   hevein	   domain	   in	   WGA,	   i.	   e.	   S114	   and	  E115,	  to	  appear	  as	  key	  factor	  to	  stabilize	  the	  complex.	  They	  form	  hydrogen	  bonds	  with	   the	  N-­‐glycan	   (Figure	  5),	   those	  which	   are	   naturally	   absent	   in	   the	   single	   hevein	   domain.	  Probably,	  this	  binding	  mode	  is	  energetically	  not	  favorable,	  if	   these	   interactions	   do	   not	   contribute	   to	   the	   binding	   en-­‐thalpy,	  as	  is	  the	  case	  of	  just	  a	  single	  hevein	  domain.	  Analogous	   STD	   experiments	   were	   carried	   out	   with	   the	  non-­‐sialylated	  N-­‐glycan	  2	  (Figure	  6).	  The	  results	  were	  very	  similar	  to	  those	  obtained	  with	  4:	  Asn	  and	  GlcNAc1	  display	  the	  strongest	  STD	  intensities,	  with	  lower	  intensities	  for	  the	  branches.	   This	   result	   supports	   the	   data	   discussed	   above,	  which	  showed	  that	  Neu5Ac	  is	  not	  involved	  in	  stable	  inter-­‐actions	  with	  the	  protein.	  As	  mentioned	   above,	  WGA	   is	   often	   included	   among	   the	  sialic	  acid-­‐binding	  lectins.	  However,	  our	  experimental	  STD	  data	  have	   shown	   that	   although	  4	   is	   indeed	   recognised	  by	  WGA,	  the	  terminal	  sialic	  acid	  of	  the	  undecasaccharide	  does	  not	   establish	   interactions	  with	   the	   lectin.	   Instead,	   the	   in-­‐teractions	   occur	   via	   the	  GlcNAc1	   and	  Asn	  moieties	   at	   the	  stem	  region	  of	  the	  glycan.	  	  To	   clarify	   this	   issue	  an	  additional	   STD	  experiment	  with	  6´-­‐sialylLacNAc	   (5)	   was	   acquired.	   The	   STD	   spectrum	  clearly	   shows	   that	   (Figure	   7)	   only	   protons	   from	   Neu5Ac	  show	  STD	  intensity,	  especially	  those	  from	  the	  acetyl	  group,	  in	   agreement	   with	   the	   X-­‐ray	   crystallographic	   data.22	   The	  other	   STD	   signals	   correspond	   to	   H5,	   H6,	   H7	   and	   H4	   of	  Neu5Ac.	  When	  presented	  in	  the	  context	  of	  an	  N-­‐glycan,	  the	  
sialic	  acid	  is	  therefore	  not	  a	  primary	  contact	  site,	  what	  it	  is	  for	   the	  branch-­‐end	  trisaccharide.	  Explicitly,	   in	   the	  4/WGA	  complex,	   only	   the	   acetyl	   group	   of	   Neu5Ac	   showed	   weak	  STD,	  and	  protons	  H5,	  H6	  and	  H7	  did	  not	  show	  STD	  (Figure	  8).	  This	   result	   underscores	   the	   inherent	   value	  of	   the	   given	  approach	   to	   team	   up	   binding-­‐site	   identification	   by	   STD	  NMR	   spectroscopy	   with	   N-­‐glycan	   synthesis.	   When	   more	  than	   one	   possible	   contact	   sites	   is	   presented	   the	   given	  strategy	  will	  decide	  on	  the	  preferences	  in	  the	  context	  of	  the	  
N-­‐glycan.	  Since	  the	  recognition	  of	  2	  and	  4	  by	  WGA	  mainly	  involves	  GlcNAc1	   and	   the	   Asn	   residue,	   it	   remained	   to	   be	   clarified	  whether	   there	   is	   an	   influence	  of	   a	   peptidic	  moiety,	   as	   oc-­‐curring	   in	   glycoproteins.	   Thus,	   an	   STD	   experiment	   was	  carried	  out	  under	   the	  same	  experimental	   conditions	   for	  a	  mixture	  of	  glycopeptide	  3	  and	  WGA.	  The	  spectrum	  showed	  STD	   intensities	  similar	   to	   those	  obtained	   for	  2	  (Figure	  9).	  In	   particular,	   the	   protons	   of	   the	   additional	   peptide	   resi-­‐dues	  did	  not	  show	  up	  in	  the	  spectrum,	  indicating	  exclusive	  recognition	  of	  3	  by	  WGA	  through	  the	  GlcNAc-­‐Asn	  region.	  	  
Maackia	  amurensis	  agglutinin	  was	  used	  as	  the	  mixture	  of	  the	  two	  lectin	  species,	  MAL	  and	  MAH.12	  Both	  isolectins	  are	  known	  to	  be	  able	  to	  bind	  to	  α2,3-­‐sialylgalactose,	  although	  with	   different	   preferences:	   the	   leukoagglutinin	   (MAL)	   is	  known	   to	   preferentially	   bind	   Neu5Acα2,3Galβ1,4βGlcNAc	  moieties	   present	   in	  N-­‐glycans,24	   	  while	   the	   hemagglutinin	  (MAH)	  has	  higher	  affinity	   for	   the	  disialylated	   tetrasaccha-­‐ride	  Neu5Acα2,3Galβ1,3[Neu5Ac(2,6)]αGalNAc	  present	   in	  
O-­‐glycans.12,	  25	  The	  binding	  sites	  of	  both	  isolectins	  are	  very	  similar,	  the	  only	  difference	  being	  the	  amino	  acids	  Y221	  and	  E222	  at	  MAL,	  that	  are	  both	  Ala	  in	  MAH.	  The	  X-­‐Ray	  crystal	  structure	  of	  MAL	  complexed	  with	  3´-­‐sialyllactose	  has	  been	  published.26	  1D	  STD	  and	  2D	  STD-­‐TOCSY	  experiments	  were	  acquired	  for	   2	   and	   4,	   using	   samples	   with	   a	   protein/ligand	   1:20	  (50uM/1mM)	  ratio.	  The	  corresponding	  spectra	  are	  shown	  in	  Figure	  10.	  The	  comparison	  of	  the	  spectra	  on	  the	  left	  (sia-­‐lylated	  N-­‐glycan	  4)	  and	  on	  the	  right	  (non-­‐sialylated	  2)	  en-­‐ables	   to	   assess	   that	   MAA	   indeed	   does	   not	   recognise	   the	  Neu5Acα(2,6)Gal-­‐containing	  molecule	  (4),	  a	  negative	  con-­‐trol	   for	   specificity,	   while	   it	   does	   efficiently	   bind	   to	   non-­‐sialylated	  2.	  From	  the	  analysis	  of	  this	  STD	  spectrum,	  it	  was	  deduced	   that	   the	   residues	   interacting	   with	   the	   lectin	   are	  the	  terminal	  galactose	  and	  GlcNAc	  residues	  (LacNAc	  unit),	  while	  in	  this	  case	  the	  GlcNAc1	  and	  Asn	  stem	  is	  not	  in	  con-­‐tact	   with	   the	   protein.	   This	   observation	   is	   in	   agreement	  with	  the	  previously	  reported	  specificity	  data	  and	  with	  the	  published	   crystallographic	   structure	   (pdb	   code	   1DBN).	  Indeed,	   the	  binding	  site	  of	  MAL	   is	  unusually	  narrow	   for	  a	  lectin.	  Both	  the	  terminal	  galactose	  and	  GlcNAc	  residues	  are	  sandwiched	  between	  Y136	  and	  Y221,	   leaving	  position	  Gal	  O6	  deep	  inside	  the	  binding	  site,	  and	  establishing	  hydrogen	  bonding	   with	   D137,	   clearly	   precluding	   the	   extension	  through	   Gal	   O-­‐6,	   as	   would	   occur	   in	   a	   2,6	   sialylated	   N-­‐glycan.	   The	   absence	   of	   sialic	   acid	   allows	   the	   terminal	  LacNAc	  unit	   to	   perfectly	   fit	   inside	   the	   binding	  pocket,	   es-­‐tablishing	   the	   combination	   of	   CH-­‐π	   stacking	   interactions	  and	   hydrogen	   bonds	   with	   Y136,	   Y221,	   and	   Y131,	   D87,	  
 D137	  and	  E224	  respectively,	   26	  a	   typical	   feature	   for	   lectin	  binding.3b	   Further	   interactions	   are	   established	   with	  GlcNAc2	  and	  ManB	  through	  Y136	  and	  Y221	  (Figure	  11).	  
Viscumin.	  This	  lectin	  is	  a	  toxic	  AB-­‐type	  protein,	  which	  in	  addition	   to	   the	   A	   chain	  with	   rRNA	  N-­‐glycosidase	   activity,	  contains	  a	  B	  chain	  with	   lectin	  activity	  to	  galactosides.	  The	  B-­‐chain	   harbors	   two	   carbohydrate-­‐binding	   sites,	   charac-­‐terised	  by	  W38	  and	  Y249.	  In	  solution,	  the	  lectin	  activity	  of	  VAA	  can	  be	  attributed	  primarily	  to	  the	  Tyr	  site.27	  The	  rec-­‐ognition	  mode	  of	  lactose	  by	  VAA	  has	  been	  characterized	  by	  X-­‐ray	   crystallography,	   chemical	   mapping	   and	  modeling.28	  It	   has	   also	   been	   reported	   that	   VAA	   strongly	   binds	  Neu5Acα2-­‐6Galβ1-­‐4GlcNAc	  on	  gangliosides	  and	  glycopro-­‐teins,	   while	   gangliosides	   with	   terminal	   galactoses	   are	  poorly	   recognised,29	   	   but	   a	   structural	   rationalization	   has	  not	  yet	  been	  given.	  Figure	  12	  shows	  the	  STD	  spectra,	  along	  with	  their	  corre-­‐sponding	  reference	  spectra,	  for	  VAA	  in	  the	  presence	  of	  the	  sialylated	   N-­‐glycan	   4	   (on	   top)	   and	   of	   the	   non-­‐sialylated	  analogue	  2	   (below).	   Both	   compounds	   are	   bound	   by	   VAA.	  Since	  strictly	  the	  same	  experimental	  conditions	  were	  kept,	  and	  the	  STD	  intensities	  are	  significantly	  stronger	  for	  4	  than	  for	  2,	   the	  results	  suggest	  respective	  grading	  of	   interaction	  for	  VAA.	  Furthermore,	   the	  distinct	  protons	  of	   the	  Neu5Ac	  residue	   (H3ax,	   H3eq	   and	   Ac)	   clearly	   revealed	   that	   this	  residue	   is	   in	   close	   contact	   with	   VAA.	   This	   fact	   was	   con-­‐firmed	   by	   the	   STD-­‐TOCSY	   spectrum	   (Figure	   13).	   Thus,	   in	  this	  case,	  the	  Neu5Ac	  moiety	  is	  clearly	  involved	  in	  the	  rec-­‐ognition	   process	   and	   its	   absence	   weakens	   the	   glycan-­‐ligand	  interaction.	  3D	   structures	   of	   the	   corresponding	   complexes	   were	  generated	  by	  using	  molecular	  modeling	  techniques,	  taking	  the	   available	   experimental	   X-­‐ray	   coordinates	   for	   the	  VAA/lactose	  complex	  as	  starting	  geometry.	  In	  the	  resulting	  3D	  structure,	  the	  galactose-­‐binding	  site	  is	  formed	  by	  amino	  acids	  D335,	  N256	  and	  Q238	  that	  establish	  hydrogen	  bond-­‐ing	   with	   the	   Gal	   residue	   and	   by	   Y249,	   which	   establishes	  stacking	   interaction	  with	   the	  α-­‐face	  of	   the	  Gal	  moiety,	  ex-­‐plicitly	   with	   H3,	   H4,	   H5	   (Figure	   14A).	   Inspection	   of	   this	  experimental	   geometry	   detects	   space	   for	   sugar	   extension	  from	  Gal	   O6.	   This	   location	   is	   surrounded	   by	   polar	   amino	  acids	  that	  may	  efficiently	  interact	  with	  sialic	  acid	  residues.	  They	  are	  S200,	  R245	  and	  Q238.	  Docking	  of	  4	  at	  this	  locus,	  using	  the	   lactose-­‐binding	  model	  as	  a	   template,	  provided	  a	  stable	   pose,	  which	  was	   further	   optimized	   through	   an	   en-­‐ergy	   minimization	   and	   MD	   protocol.	   Of	   note,	   further	  interactions	  can	   then	   take	  place	  between	  Neu5Ac	  and	   the	  above	   mentioned	   polar	   residues	   (Figure	   14B):	   R245	  establishes	   a	   bidentate	   hydrogen	   bond	   with	   the	   glycerol	  chain	  of	  the	  sialic	  acid	  residue,	  S200	  is	  hydrogen	  bonded	  to	  the	   carboxylic	   acid,	   and	   Q238	   establishes	   a	   cooperative	  hydrogen	   bond	   with	   OH7	   of	   Neu5Ac	   and	   OH3	   of	   the	  branching	  GlcNAc.	  Evidently,	   these	   interactions	   appear	   to	  underlie	  the	  preferential	  reactivity	  reported	  above.	  	  
Discussion	  The	   availability	   of	   synthetic	  N-­‐glycans	   facilitates	   to	   de-­‐fine	   the	  docking	  sites	  of	   lectins.	  Shown	  herein,	   the	  nature	  of	  the	  target	  epitope	  strictly	  depends	  on	  the	  nature	  of	  the	  tested	   lectin,	   which	   can	   select	   distinct	   fragments	   of	   the	  
complex-­‐type	   saccharide	   chain	   with	   exquisite	   specificity,	  depending	   on	   the	   relative	   presentation	   of	   the	   different	  residues	  and	  the	  architecture	  of	  the	  binding	  site.	  	  We	   have	   underscored	   the	   importance	   of	   multivalency	  for	   achieving	   glycan	   binding	   in	   the	   case	   of	   a	   comparison	  between	   a	   single	   hevein	   domain	   and	   WGA.	   Where	   the	  monomeric	   unit	   does	   not	   recognise	   the	   large	   glycan,	   the	  branching	   at	   the	   βMan	   residue	   being	   the	   key	   structural	  element	   for	   precluding	   the	   interaction	   the	   multi-­‐domain	  lectin	   binds	   the	   terminal	   reducing	   end	   of	   either	   2	   or	   4,	  namely	  the	  GlcNAc-­‐Asn	  epitope,	  owing	  to	  the	  possibility	  of	  achieving	  additional	  inter-­‐site	  stabilizing	  interactions	  from	  one	  of	   the	  neighboring	  hevein	  domains.	   In	   this	   context,	   it	  has	  to	  be	  emphasized	  that	  WGA	  does	  not	  react	  with	  2	  or	  4	  through	  the	  (GlcNAc)2	  	  moiety,	  at	  it	  would	  be	  expected.	  The	  chemical	  nature	  of	  this	  branched	  glycan	  excludes	  the	  pos-­‐sibility	   of	   efficient	   interactions	   of	   the	   diacetylchitobiose	  stem	  with	  the	  two	  consecutive	  aromatic	  residues,	  typical	  of	  hevein	  domains,	  the	  recognized	  epitope	  is	  shifted	  one	  posi-­‐tion	  to	  the	  GlcNAc-­‐Asn	  fragment.	  Clearly,	  the	  sialyl	  residue	  of	  4	  is	  not	  involved	  in	  the	  binding	  process,	  although	  it	  has	  been	  demonstrated	  that	  WGA	  also	  can	  accommodate	  sialic	  acid	   residues.	   Indeed,	   using	  α2,6-­‐sialyllactose,	   we	   clearly	  demonstrate	  that	  this	  small	  trisaccharide	  is	  recognized	  by	  WGA.	   Thus,	   although	   presented	   at	   the	   spatially	   readily	  accessible	   non-­‐reducing	   end,	   binding	   occurs	   exclusively	  via	   the	   glycan-­‐Asn	   stem	   region,	   a	   result	   of	   conspicuous	  importance	   for	   interpretation	  of	  data	  using	  WGA	   in	  array	  platforms.	  The	  same	  holds	  true	  for	  MAA,	  for	  which	  reactiv-­‐ity	  to	  the	  LacNAc	  terminus	  is	  detectable.	  	  As	  conclusion,	  the	  wide	  variety	  with	  the	  glycome	  and	  of	  lectin	   architectures	   is	   a	   challenge	   for	   analyzing	   protein-­‐lectin	   interactions.	   Advances	   in	   macroscopic	   analysis	   of	  binding	   using	   array-­‐based	   and	   other	   technologies30	   can	  strategically	   be	   complemented	   by	   the	   given	   approach,	   to	  rigorously	  define	  the	  contact	  site	  in	  naturally	  complex	  gly-­‐cans.	   Work	   with	   VAA	   yielded	   insights	   into	   how	   α2,6-­‐sialylation	   is	   accommodated,	   here	   identifying	   resonances	  from	   protons	   of	   the	   sialic	   acid	   and	   a	   network	   of	   interac-­‐tions.	   Thus,	   the	   combination	   of	   N-­‐glycan	   synthesis,	   STD	  NMR	   spectroscopy	   and	   modeling	   proves	   its	   potency	   to	  detect	  and	  characterize	  epitope	  interaction.	  	  	  
ASSOCIATED	  CONTENT	  	  1H	   NMR	   spectra	   for	   the	   titration	   of	  WGA-­‐B	   domain	   with	   in-­‐creasing	  amounts	  of	  the	  sialylated	  N-­‐glycan	  4.	  This	  material	  is	  available	  free	  of	  charge	  via	  the	  Internet	  at	  http://pubs.acs.org.	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  FIGURE	  1.	  Glycan	  structures	  used	  in	  this	  study.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
	  FIGURE	  2.	  A:	  The	  complex	  of	  hevein	  with	  the	  trisaccharide	  core	  (3)	  as	  deduced	  from	  NMR.19	  B:	  Attempted	  docking	  of	  the	  extended	  

























































































	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  






	  FIGURE	  13.	  	  A.	  TOCSY	  spectrum	  of	  sialylated	  N-­‐glycan	  4.	  B.	  STD-­‐TOCSY	  of	  VAA	  	  with	  4.	  The	  sialyl	  residue	  is	  in	  contact	  to	  the	  lectin	  surface.	  
	  
	  FIGURE	  14.	  	  A.	  X-­‐ray	  structure	  (pdb	  code	  1PUU)	  of	  VAA	  complexed	  with	  lactose.	  The	  amino	  acids	  implicated	  in	  interactions	  with	  the	  ligand	  are	  highlighted.	  B.	  Docking	  pose	  of	  the	  sialylated	  N-­‐glycan	  4	  on	  the	  Tyr-­‐site	  in	  subdomain	  2γ.	  The	  new	  amino	  acids	  pro-­‐viding	  further	  interactions	  (hydrogen	  bonds	  depicted	  in	  green)	  with	  the	  Neu5Ac	  residues	  are	  highlighted.	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